Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-29T17:38:51.614Z Has data issue: false hasContentIssue false
  • English
  • Français

Biological correlates of personality: considerations on the possible usefulness of central nervous system peripheral markers

Published online by Cambridge University Press:  16 April 2020

P Castrogiovanni ,
F Pieraccini ,
I Maremmani  and
D Marazziti
P Castrogiovanni
Affiliation:
Department of Psychiatry, University of Pisa, Via Roma, 67, 56100Pisa, Italy
F Pieraccini
Affiliation:
Department of Psychiatry, University of Pisa, Via Roma, 67, 56100Pisa, Italy
I Maremmani
Affiliation:
Department of Psychiatry, University of Pisa, Via Roma, 67, 56100Pisa, Italy
D Marazziti*
Affiliation:
Department of Psychiatry, University of Pisa, Via Roma, 67, 56100Pisa, Italy
*
*Correspondence and reprints.
Get access

Summary

Although a great deal of biological research has been carried out on several psychiatric disorders, it is disappointing to see how little progress has been made in the field of the biology of personality. The authors underline the methodological problems that arise in the investigation of biological substrates of human personality and review both currently available and putative peripheral markers of the central nervous system that might be used in further human studies.

Keywords

personalityneurotransmitterMMPIperipheral CNS marker3H-imipramine bindingMAO-B activityelectroretinogram- b wave amplitude
Type
Review
Information
European Psychiatry , Volume 8 , Issue 3 , 1993 , pp. 115 - 124
Copyright
Copyright © Elsevier, Paris 1993

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aberg-Wistedt, ARoss, SBJostell, KGSjoqvist, B (1982) A double-blind study of a 5HT uptake inhibitor in endogenous depression. Acta Psychiatr Scand 66, 66–82CrossRefGoogle Scholar
Aberg-Wistedt, ARoss, SBJostell, KGSjoqvist, B (1984) A double-blind study of zimelidine, a serotonin uptake inhibitor, and desimipramine, a norepinephrine uptake inhibitor, in endogenous depression: clinical and biochemical findings, Adv Biochem Psychopharmacol 39, 439–447Google Scholar
Agren, H (1980) Symptom pattern in unipolar and bipolar depression correlating with monoamine metabolites in cerebrospinal fluid. Psychiatry Res 3, 211–224CrossRefGoogle Scholar
Agren, H (1983) Life at risk: markers of suicidally in depression. Psychiatr Dev 1, 87–104Google Scholar
American Psychiatric Association (1980) DSM III: Diagnostic and Statistical Manual of Mental Disorders. 3dedn, Washington, DC, The AssociationGoogle Scholar
Arora, RCMeltzer, HY (1984) Imipramine binding in subpopulations of normal human blood platelets. Biol Psychiatry 19, 257–262Google ScholarPubMed
Asberg, MBertilsson, CLMaertenson, BScalia-Tomba, GPThoren, PTraskman-Bendz, E (1984) Cerebrospinal fluid monoamine metabolites in melancolia. Acta Psychiatr Scand 69, 201–219CrossRefGoogle Scholar
Asberg, MTraskman, LThoren, P (1976) 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor? Arch Gen Psychiatry 33, 1193–1197CrossRefGoogle ScholarPubMed
Azzaro, AJAmedro, JBBrown, LMSmith, DJWilliams, GM (1988) The effects of selective type A or type B monoamine oxidase inhibition on the intrasynaptosomal deamination of 3H-serotonin in rat spinal cord tissue. Naunyn Schmiedeberg's Arch Pharmacol 338, 9–13CrossRefGoogle ScholarPubMed
Banki, CMMolnar, GVojnik, M (1983) Cerebrospinal fluid amine metabolites, tryptophan and clinical parameters in depression. J Affect Dis 3, 91–99CrossRefGoogle Scholar
Baron, MBatkai, AGruen, RKowalik, SQuitkin, F (1983) 3H-imipramine binding sites in unipolar depression. Biol Psychiatry 18, 1403–1409Google ScholarPubMed
Baron, MBarkai, AGruen, RPeselow, EFieve, RRQuitkin, F (1986) Platelet 3H-imipramine binding sites in affective disorders: Trait versus status characteristics. Am J Psychiatry 143, 711–717Google Scholar
Berrettini, WHBardakjian, JCappellari, CBBarnett, AL JrAlbright, ANurnberger, JIGershon, ES (1987) Skin fibroblast beta-adrenergic receptor function in manic-depressive illness. Biol Psychiatry 22, 1439–1443CrossRefGoogle ScholarPubMed
Briley, MSLanger, SZRaisman, R (1979) Human platelets possess high-affinity binding sites for 3H-imipramine, Eur J Pharmacol 58, 347–348CrossRefGoogle Scholar
Briley, MSLanger, SZRaisman, RSechter, DZarifian, E (1980) Tritiated imipramine binding sites are decreased in platelets from untreated depressed patients.Science 209, 303–305CrossRefGoogle ScholarPubMed
Brown, GLGoodwin, FKBallanger, JCGoyer, PFMajor, LF (1979) Aggression in humans correlates with cerebrospinal fluid metabolites. Psychiatry Res 1.131–139CrossRefGoogle Scholar
Buchsbaum, MSCoursey, RDMurphy, DL (1976) The biochemical high-risk paradigm: behavioural and familial correlates of low platelet MAO activity. Science 194, 339–341CrossRefGoogle Scholar
Buchsbaum, MSHaier, RJ (1983) Psychopathology: biological approaches. Ann Rev Psychol 34, 401–430CrossRefGoogle ScholarPubMed
Bunney, WE (1975) The current status of research in the catecholamine theories of affective disorders. Psycho-Pharmacol Commun 1, 599–600Google ScholarPubMed
Bunney, WE JrMurphy, DLGoodwin, FK (1970) The switch process from depression to mania: relationship to drugs which alter brain amines. Lancet i, 1022–1027CrossRefGoogle Scholar
Butler, PRAnderson, RJVenton, DL (1983) Human platelet phenol sulphotransferase: partial purification and detection of two forms of the enzyme. J Neurochem 41, 630–639CrossRefGoogle ScholarPubMed
Carter, CJPycock, CJ (1977) Possible importance of 5-hydroxytryptamine in neuroleptic-induced catalepsy in rats. Br J Pharmacol 60, 267Google ScholarPubMed
Castels, SChakrabarti, CWindsberg, BCHurwic, MPerel, JMNyhan, WL (1979) Effect of l-5-hydroxytryptophan on monoamine and aminoacid turnover in the Lesch-Nyhan syndrome. J Autism Dev Disord 9, 95–98CrossRefGoogle Scholar
Castrogiovanni, PCapone, MRMaremmani, IMarazziti, D (1993) Platelet serotonergic markers and aggressive behaviour in healthy subjects. Neuropsychobiol (in press)CrossRefGoogle Scholar
Castrogiovanni, PMaremmani, IAndreani, MFPieroni, FRegoli, FPerossini, MFornaro, P (1985) Contributo alia valutazione dell'aggressività nell'uomo in un tentativo di approccio psicologico e biologico. Rivista di Psichiatria 20, 18–33Google Scholar
Castrogiovanni, PMaremmani, IBongioanni, PMarazziti, D (1991) Platelet MAO activity and behavioural characteristics in humans. Neuropsychobiol 23, 173–179CrossRefGoogle Scholar
Castrogiovanni, PMaremmani, IDi Muro, ARotondo, AMarazzili, D (1992) Personality features and platelet 3H-imipramine binding. Neuropsychobiol 25, 11–13CrossRefGoogle ScholarPubMed
Castrogiovanni, PMaremmani, IMarazziti, DCorradi, I (1989) Attività dopaminergica nell'uomo e caratteristiche di personality. In: Progressi in Psichiatria. Psichiatria e Neuroscienze Vol I (Pancheri, PReda, GC eds). Roma, 129–133Google Scholar
Cloninger, CR (1986) A unified biosocial theory of personality and its role in the developement of anxiety states. Psychiatric Dev 3, 167–226Google Scholar
Cloninger, CR (1987) A systematic method for clinical description and classification of personality variants: a proposal. Arch Gen Psychiatry 44, 573–588CrossRefGoogle ScholarPubMed
Cooper, SJKelly, JKing, DJ (1985) Adrenergic receptors in depression: effects of electroconvulsive therapy. Br J Psychiatry 1147, 23–27CrossRefGoogle Scholar
Daiguji, MMeltzer, HTTong, CU'Prichard, DCYoung, MKravitz, H (1981) Alpha-2 adrenergic receptors in platelet membranes of depressed patients: no change in number of 3H-yohimbine affinity. Life Sci 29, 2059–2064CrossRefGoogle ScholarPubMed
Davis, JMKoslow, SHGibson, RD (1988) Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls. Arch Gen Psychiatry 45, 705–711CrossRefGoogle ScholarPubMed
Esler, MTurbott, JSchwarz, RLeonard, PBobik, ASkews, HJackman, G (1982) The peripheral kinetics of norepinephrine in depressive illness. Arch Gen Psychiatry 32, 295CrossRefGoogle Scholar
Eysenck, HJ (1988) Discussions arising from: Cloninger CR “A unified biosocial theory of personality and its role in the development of anxiety states”. Psychiatric Dev 1, 73–74Google Scholar
Filip, VBalik, J (1978) Possible indications of dopaminergic blockade in man by electroretinography. Int Pharmacopsychiatr 13, 151CrossRefGoogle Scholar
Fornaro, PPerossini, MPlacidi, GFDell'Osso, LTassi, GCastrogiovanni, P (1984) Electroretinography (ERG) as a tool of investigation of dopaminergic activity in man. Res Commun Psychol Psvchiatr Behav 9, 307–323Google Scholar
Galvin, GShekhar, ASimon, JStilwell, BEyck, RTLaite, GKarwisch, GBlix, S (1991) Low dopamine beta-hydroxylase: a biological sequela of abuse and neglect? Psychiatry Res 39, 1–11CrossRefGoogle ScholarPubMed
Garcia-Sevilla, JAGuimon, JGarcia-Vallejo, PFuster, MJ (1986) Biochemical and functional evidences of supersensitive platelet alpha 2-adrenoreceptors in major affective disorders. Effect of long-term lithium carbonate treatment. Arch Gen Psychiatry 43, 51–57CrossRefGoogle Scholar
Garcia-Sevilla, JAZis, APHollingsworth, P (1981) Platelet alpha-2-adrenergic receptors in major depressive disorders. Arch Gen Psychiatry 138, 1327–1333Google Scholar
Gelder, MG (1987) Discussions arising from: Cloninger CR “A unified biosocial theory of personality and its role in the developement of anxiety states”. Psychiatric Dev 4, 387–391Google Scholar
Goodwin, FKPost, RMDunner, DLGordon, EK (1973) Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique. Am J Psychiatry 130, 73–79CrossRefGoogle ScholarPubMed
Goodwin, FKRoy-Birne, PP (1987) Future directions in biological Psychiatry. In: Psychopharamcology: the Third Generation of Progress (Mellzer, HY ed). Raven, New York, 1691–1698Google Scholar
Gottfries, CGVon Knorring, LOreland, L (1980) Platelet monoamine oxidase activity in mental disorders: affective psychoses and suicidal behavior. Prog Neuro-Psychopharmacol 4, 185–192CrossRefGoogle ScholarPubMed
Gray, JA (1987) Discussions arising from: Cloninger CR “A unified biosocial theory of personality and its role in the development of anxiety states”. Psychiatric Dev 4, 377–385Google Scholar
Greenspan, KSchildkraut, JJGordon, EKLevy, BDurell, J (1969) Catecholamine metabolism in affective disorders. Arch Gen Psychiatry 21, 710–716CrossRefGoogle ScholarPubMed
Haier, RJBuchsbaum, MSMurphy, DLGottesman, IICoursey, RD (1980) Psychiatric vulnerability, monoamine oxidase, and the average evoked potential.Arch Gen Psychiatry 37, 340–345CrossRefGoogle ScholarPubMed
Haier, RJMurphy, DLBuchsbaum, MS (1979) Paranoia and platelet MAO in normals and nonschizophrenic psychiatric groups. Am J Psychiatry 136, 308–310Google ScholarPubMed
Healy, DCarney, PALeonard, BE (1983) Monoamine-related markers of depression. Changes following treatment. J Psychiatry Res 17, 251–260CrossRefGoogle Scholar
Jimerson, DCInsel, TRReus, VIKoppin, IJ (1983) Increased plasma MHPG in dexamethasone-resistant depressed patients. Arch Gen Psychiatry 40, 173–179CrossRefGoogle ScholarPubMed
Klinterberg, AOreland, LHallman, JWirsén, ALevander, JLSchalling, D (1990) Exploring the correlations between platelet MAO activity and behavior. Neuropsychobio 91, 188–196CrossRefGoogle Scholar
Korsgaard, SGerlach, JChristensson, E (1985) Behavioral aspects of serotonin-dopamine interaction in the monkey. Eur J Pharmacol 118, 245–252CrossRefGoogle ScholarPubMed
Koslow, SHMaas, JWBowden, CLDairs, JMHanin, IJavaid, J (1983) CSF and urinary biogenic amines and metabolites in depression and mania. Arch Gen Psychiatry 40, 999–1014CrossRefGoogle ScholarPubMed
Lahmeyer, HWVal, EGaviria, FMPrasad, RBPandey, GNRodgers, PWeiler, MAAltman, EG (1988) EEG sleep, lithium transport, dexamethasone suppression, and monoamine oxidase activity in borderline personality disorder. Psychiatry Res 25, 19–30CrossRefGoogle ScholarPubMed
Langer, SZRaisman, R (1983) High-affinity binding of 3H-imipramine and 3H-desipramine: Biochemical tools for studies in depression. Life Sci 29, 221–220Google Scholar
Le Fur, GPhan, TUzan, A (1980) Identification of stereospecific 3H-spiroperidol binding sites in mammalian lymphocytes. Life Sci 26, 1139–1148CrossRefGoogle ScholarPubMed
Levitt, PPintar, JEBraekefield, XO (1982) Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonin neurons. Proc Natl Acad Sci USA 79, 6385–6389CrossRefGoogle Scholar
Lewis, DAMcChesney, C (1985) Tritiated imipramine binding distinguishes among subtypes of depression,Arch Gen Psychiatry 42, 485–488CrossRefGoogle ScholarPubMed
Lewis, DANoyes, RJCoryell, WClancy, S (1985) Tritiated imipramine binding to platelets is decreased in patients with agoraphobia. Psychiatry Res 6, 2–9Google Scholar
Liebowitz, MR (1987) Discussions arising from: Cloninger CR “A unified biosocial theory of personality and its role in the development of anxiety states”, Psychiatric Dev 4, 385–387Google Scholar
Limson, RGoldman, DRoy, ALimparsky, DRavitz, BAdinoff, BLinnoila, M (1991) Personality and cerebro-spinal fluid monoamine metabolites in alcoholics and controls. Arch Gen Psychiatry 48, 437–441CrossRefGoogle ScholarPubMed
Lindstrom, LH (1985) Low HVA and normal 5-HIAA CSF levels in drug free schizophrenia patients, compared to healthy volunteers: correlations to symptomatology and heredity. Psychiatry Res 14, 265–274CrossRefGoogle Scholar
Linnoila, MVirkkunen, MScheinin, MNuutila, ARimon, RGoodwin, FK (1983) Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from non-impulsive violent behavior. Life Sci 33, 2609–2614CrossRefGoogle Scholar
Maas, JW (1984)Relationships between central nervous system noradrenergic function and plasma and urinary concentrations of norepinephrine metabolites. In: Frontiers in Biochemical and Pharmacological Research in Depression, (Usdin, E ed). Raven Press,New York, 45–55Google Scholar
Maas, JWKocsis, JHBowden, CLDavis, JMRedmond, DEHanin, IRobins, E (1982) Pretreatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment. Psychol Med 12, 37–43CrossRefGoogle ScholarPubMed
Mann, JJBrown, RPHalper, JPSweeney, JAKocsis, JHStokes, PEBilezikian, JP (1985) Reduced sensitivity of lymphocyte beta-adrenergic receptors in patients with endogenous depression and psychomotor agitation. N Engl J Med 313, 715–719CrossRefGoogle ScholarPubMed
Marazziti, DBalestri, CCappiello, MMaremmani, ICastrogiovanni, P (1991) Platelet sulfotransferase activity: a peripheral marker of the dopamine system? N Trends Exp Clin Psychiatr 3, 107–111Google Scholar
Marazziti, DDe Leo, DConti, L (1989) Further evidence supporting the role of the serotonin system in suicidal behavior: a preliminary study in suicide attempters. Acta Psychiatr Scand 80, 322–324CrossRefGoogle ScholarPubMed
Marazziti, DMacchi, ERotondo, APlacidi, GFCassano, GB (1988) Involvement of serotonin system in bulimia. Life Sci 43, 2123–2126CrossRefGoogle ScholarPubMed
Marazziti, DPlacidi, GFCassano, GBAkiskal, SH (1989) Lack of specificity of reduced platelet imipramine binding in different psychiatric conditions. Psychiatry Res 30, 21–29CrossRefGoogle ScholarPubMed
Murphy, DLCoursey, RDHaenel, T (1982) Platelet monoamine oxidase as a biological marker in the affective disorders and alcoholism. In: Biological Markers in Psychiatry and Neurology (Udsin, EHanin, I eds). Pergamon Press, Oxford,123CrossRefGoogle Scholar
Meyerson, LRIeni, JRWennogle, LP (1987) Allosteric interactions between the site labeled by 3H-imipramine and the serotonin transportation in human platelets. J Neurochem 48, 560–565CrossRefGoogle Scholar
Murphy, DLWright, CBuchsbaum, MSNichols, ACosta, JLWyatt, RJ (1976) Platelet and plasma monssaminoxidase activity in 680 normals: sex and age differences and stability over lime. Biochem Med 16, 254–265CrossRefGoogle Scholar
Ninan, PTvan Kammcn, DPScheinin, MLinnoila, MBunney, WE JrGoodwin, FK (1984) CSF 5-HIAA in suicidal schizophrenic patients. Am J Psychiatry 141, 566–569Google ScholarPubMed
Nurnberger, JJ (1988) Discussions arising from: Cloninger CR “A unified biosocial theory of personality and its role in the development of anxiety states”. Psychiatric Dev 1, 75–79Google Scholar
Oreland, Lvon Knorring, L (1984) Platelet MAO: a biological marker for increased vulnerability. CI Neuropharmacol 7, 762–763Google Scholar
Pandey, GNDysken, MWGarver, DLDavil, JM (1979) Beta-adrenergic receptor function in affective illness. Am J Psychiatry 136, 675–678Google ScholarPubMed
Papeschi, RMcClure, DJ(1971)Homovanillic and 5-hydroxyindoleacetic acid in cerebrospinal fluid in depressed patients. Arch Gen Psychiatry 25, 354–358CrossRefGoogle ScholarPubMed
Paul, SMRehavi, MRice, KCIttah, YSkolnick, P (1981) Does high-affinity 3H-imipramine binding label serotonin reuptake sites in brain and platelets? Life Sci 28, 2753–2760CrossRefGoogle Scholar
Paul, SMRehavi, MSkolnick, PGoodwin, FK (1980) Demonstration of specific high-affinity binding sites for 3H-imipramine in human platelets. Life Sci 26, 953–959CrossRefGoogle ScholarPubMed
Paul, SM (1986) Serotonin reuptake in platelets and human brain: clinical implications. Paper read at the WPA Regional Symposium Copenhagen, DenmarkGoogle Scholar
Paykel, ESParker, RRPenrose, RJ (1979) Depressive classification and prediction of response to phenelzine. Br J Psychiatry 134, 572–581Google Scholar
Pimoule, CBriley, MSGay, CLoo, HSZarifian, ERaisman, RLanger, SZ (1983) 3H-rauwolscine binding in platelets from depressed patients and healthy volunteers. Psychopharmacol 79, 308–312CrossRefGoogle ScholarPubMed
Post, RMGoodwin, FK (1978) Approaches to brain amines in psychiatric patients: a reevaluation of cerebrospinal fluid studies. In: Handbook of Psychopharmacology (Iversen, LLIversen, SDSnyder, SH eds). Plenum Press, New York,147–185CrossRefGoogle Scholar
Prasad, AJ (1985) Neuroendocrine differences between violent and non-violent parasuicides. Neuropsychobiology 13, 157–159CrossRefGoogle ScholarPubMed
Raisman, RSechter, DBriley, MSZarifian, ELanger, SZ (1981) High-affinity 3H-imipramine binding in platelets from untreated and treated patients compared to healthy volunteers. Psychopharmacol 75, 368–371CrossRefGoogle ScholarPubMed
Reisi, CHaier, RJDeMet, EChicz-DeMet, A (1991) Platelet MAO activity in personality disorders and normal controls. Psychiatry Res 33, 221–227Google Scholar
Rice, JMcGuffin, PShaskan, EG (1982) A commingling analysis of platelet monoamine oxidase activity. Psychiatry Res 7, 325–335CrossRefGoogle ScholarPubMed
Rogeness, GAAmrung, SAHarris, WR (1984) Clinical characteristics of emotionally disturbed boys with very low activities of dopamine β-hydroxylase. J Am Acad Child Psychiatry 23, 203–208CrossRefGoogle ScholarPubMed
Rogeness, GAAmrung, SAHoppe, SK (1986) Near-zero plasma dopamine β-hydroxylase and conduct disorder in emotionally disturbed boys. J Am Acad Child Psychiatry 25,421–527CrossRefGoogle ScholarPubMed
Rogeness, GAHernandez, JMMacedo, CAMitchell, EL (1982) Biochemical differences in children with conduct disorder socialized and undersocialized. Am J Psychiatry 139, 307–311Google ScholarPubMed
Rogeness, GAJavors, MAMaas, JWMacedo, CA (1982) Catecholamines and diagnosis in children. J Am Acad Child Psychiatry 29, 234–241CrossRefGoogle Scholar
Rogeness, GAMaas, JWJavors, MAMacedo, CAHarris, WRHoppe, SK (1988) Diagnosis, catecholamine metabolism, and plasma dopamine β-hydroxylase. J Am Acad Child Psychiatry 27, 121–125CrossRefGoogle Scholar
Roy, ALinnoila, M (1988) Discussions arising from: Cloninger CR “A unified biosocial theory of personality and its role in the developement of anxiety states”. Psychiatric Dev 1, 79–81Google Scholar
Roy, AEverett, DPickar, DPaul, SM (1987) Platelet imipramine binding and serotonin uptake in depressed patients and controls: relationship to plasma Cortisol levels before and after dexametasone administration. Arch Gen Psychiatry 44, 320–327CrossRefGoogle Scholar
Schalling, DAsberg, MEdman, GOreland, L (1987) Markers for vulnerability to psychopalhology: temperament traits associated with platelet MAO activity. Acta Psychiatr Scand 76, 172–182CrossRefGoogle Scholar
Schildkraut, JJ (1975) Depression and biogenic amines. In: American Handbook of Psychiatry (Hambourg, D ed). Basic Books, New York, 609–672Google Scholar
Schildkraut, JJ (1978) Current status of the catecholamine hypothesis of affective disorders. In Psychopharmacology: a Generation of Progress (Lipton, MAdi Mascio, D eds). Raven Press, New York, 1233–1234Google Scholar
Sedvall, GFyro, BGullberg, BNybaeck, HWiesel, FAWode-Helgodt, B (1980) Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity. Br J Psychiatry 136, 366–374CrossRefGoogle ScholarPubMed
Shekim, WODavis, LGBylund, DBBrunngraber, EFikes, LLanham, J (1982) Platelet MAO in children with attention deficit disorder ami hyperactivity: a pilot study. Am J Pychiatry 139, 936–938Google Scholar
Siever, LJ (1987) Role of noradrenergic mechanisms in the etiology of affective disorders. In: Psychopharmacology: the third Generation of Progress (Meltzer, HY ed). Raven Press, New York, 493–504Google Scholar
Sneddon, JM (1973) Blood platelets as a model for monoamine containing neurons. Prog Neurobiol 1, 151–198CrossRefGoogle Scholar
Stahl, SM (1977) The human platelets. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurological disorders. Arch Gen Psychiatry 34, 509–516CrossRefGoogle Scholar
Suranyi-Cadotte, BEQuirion, RMcQuide, P (1984) Platelet 3H-imipramine binding: A state dependent marker in depression. Pro Neuropsychopharmacol Biol Psychiatry 8, 731–741Google ScholarPubMed
Theodora, EHale, DSDavies, SLKatona, CLEYamaguchi, YHorton, RWKelly, JSPaykel, ES (1986) Platelet high affinity adrenoceptor binding sites labelled with the agonist 3H-UK-14,304 in depressed patients and matched controls. Eur J Pharmacol 126, 329–332CrossRefGoogle Scholar
Traskman, LAsberg, MBertilsson, LSjostrand, L (1981) Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 38, 631–636CrossRefGoogle ScholarPubMed
Tuomisto, JTukiainen, E (1976) Decreased uptake of 5HT in blood platelets from depressed patients. Nature 262, 596–598CrossRefGoogle Scholar
Van Praag, HM (1980) Central monoamine metabolism in depression. Serotonin and related compounds. Comp Psychiatry 21, 30–35CrossRefGoogle ScholarPubMed
Van Praag, HM (1982) Neurotransmitters and CNS disease: depression. Lancet ii, 1259–1264CrossRefGoogle Scholar
Van Praag, HM (1983) CSF 5-HIAA and suicide in non-depressed schizophrenics. Lancet ii, 977–978CrossRefGoogle Scholar
Van Praag, HMDe Haan, S (1979) Central serotonin metabolism and the frequency of depression. Psychiatry Res 1,219–224CrossRefGoogle Scholar
Van Praag, HMKahn, RSAsnis, GMWetzler, SBrown, SLBleich, AKorn, ML (1987) Denosologization of biological psychiatry or the specificity of 5HT disturbances in psychiatric disorders. J Affective Dis 13, 1–8CrossRefGoogle ScholarPubMed
Van Praag, HMKorf, JLakke, JPWFet al (1975) Dopamine metabolism in depression, psychoses and parkinson's disease: the problem of the specificity of biological variables in behaviour disorders. Psychol Med 5, 138–146CrossRefGoogle Scholar
Vestergaard, PSorensen, THoppe, ERafaelsen, OJYates, CMNicolau, N (1978) Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders. Acta Psychiatr Scand 58, 88–96CrossRefGoogle ScholarPubMed
Vestergaard, PSorensen, THoppe, ERafaelsen, OJYates, CMNicolau, N (1978) Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorder. Acta Psychiatr Scand 58, 88–96CrossRefGoogle Scholar
Von Knorring, LOreland, LVon Knorring, AL (1987) Personality traits and platelet MAO activity in alcohol and drug abusing teenage boys. Acta Psychiatr Scand 75, 307–314CrossRefGoogle ScholarPubMed
Waegner, AAberg-Wistedt, AAsberg, MEkquist, BMartenson, BMontero, D (1985) Lower 3H-imipramine binding in platelets from untreated depressed patients compared with healthy controls. Psychiatry Res 16, 131–139CrossRefGoogle Scholar
Waldmeier, PCDelini Stula, AA (1979) Serotonin-dopamine interactions in the nigro-striatal system. Eur J Pharmacol 55, 363–373CrossRefGoogle Scholar
Weizman, ACarmi, MTyano, SApter, ARehavi, M (1986) 3H-imipramine binding and serotonin uptake to platelets of adolescent females suffering from anorexia nervosa. Life Sci 38, 1235–1242CrossRefGoogle ScholarPubMed
Weizman, RCarmi, MHermesh, HShahar, AApter, ATyano, SRehavi, M (1986) High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients. Am J Psychiatry 143,335–339Google ScholarPubMed
Wennogle, LPMeyerson, LR (1984) Serotonin modulates the dissociation of 3H-imipramine from human platelet recognition sites. Eur J Pharmacol 86, 303–307CrossRefGoogle Scholar
Wyatt, RJPortnoy, BKupfer, DJSnyder, FEngelman, K (1971) Resting plasma catecholamine concentrations in patients with depression and anxiety. Arch Gen Psychiatry 24, 65–70CrossRefGoogle ScholarPubMed
Wyatt, RJPotkin, SOBridge, TPPhelps, BHWise, CD (1980) Monoamine oxidase in schizophrenia: an overview. Schizophen Bull 6, 199–207CrossRefGoogle ScholarPubMed
Yehuda, RSouthwick, SMEdell, WSGiller, EL (1989) Low platelet monoamine oxidase activity in borderline personality disorder. Psychiatry Res 30, 265–273CrossRefGoogle ScholarPubMed
Young, WFLaws, ERSharbrough, EWWeishilboum, RM (1985) Human phenol sulfotransferase: correlation of brain and platelet activities. J Neurochem 144, 1131–1137CrossRefGoogle Scholar
Young, WFJOkazaki, HLaws, ERJWeishilboum, RM (1984) Human brain phemol sulphotransferase: biochemical properties and regional localization. J Neurochem 43, 706–715CrossRefGoogle Scholar
Zuckerman, MBuchsbaum, MSMurphy, DL (1980) Sensation seeking and its biological correlates. Psychol Bull 88, 187–214CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.